Wenzhen Ge, PhD

Regeneron Pharmaceuticals

Poster(s):

• (AE) Shifting Treatment Landscape and Overall Survival by PD-L1 Expression Level Among Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC)
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (72) Trends and Disparities in Real-World Biomarker Testing and Overall Survival (OS) Among US Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC), 2015–2020
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST